ePrivacy and GPDR Cookie Consent by TermsFeed Generator

MONTELUKAST MYLAN

4MG TBL MND 30

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Interruption of marketing 25.04.2022 0117463, 0144691, 0144699, 0153248, 0165601, 0184055
Manufacturing reasons 31.5.2022
Placing on the market 23.12.2019

All reports are available in the Overview.

Back to list